Note of clarification of data in the paper entitled association between BRIP1 (BACH1) polymorphisms and breast cancer risk

Breast Cancer Research and Treatment
Yadong WangHaiyu Wang

Abstract

With great interest, we read the recent article entitled "Association between BRIP1 (BACH1) polymorphisms and breast cancer risk: a meta-analysis" published online in Pabalan et al. (Breast Cancer Res Treat 137:553-558, 2013). This article suggests that overall summary estimates imply no associations but suggest susceptibility among carriers of the C47G polymorphism and Pro-Ser genotype in premenopausal women. The result is encouraging. Nevertheless, several key issues in this meta-analysis are worth noticing.

References

Jan 25, 2006·BMC Cancer·Pia VahteristoHeli Nevanlinna
May 17, 2007·BMC Cancer·Bernd FrankBarbara Burwinkel
Jun 2, 2009·Journal of Cancer Research and Clinical Oncology·Xiang HuoJinhai Tang
Aug 29, 2009·Breast Cancer Research and Treatment·Maria A LoizidouKyriacos Kyriacou
Dec 18, 2010·Breast Cancer Research and Treatment·Valentina SilvestriLaura Ottini
Dec 12, 2012·Breast Cancer Research and Treatment·Noel PabalanHilmi Ozcelik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.